30 studies found for:    Benign Essential Blepharospasm
Show Display Options
Rank Status Study
1 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
2 Completed
Has Results
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Acetyl-Hexapeptide Topical Treatment;   Drug: placebo
3 Completed Blepharospasm Patient Survey for Patients With Blepharospasm
Condition: Blepharospasm
Intervention: Other: No intervention- only one time survey
4 Completed Brain Changes in Blepharospasm
Condition: Blepharospasm
Intervention:
5 Completed Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Biological: Xeomin®
6 Completed
Has Results
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Biological: Botulinum Toxin Type A 900kDa;   Biological: Botulinum Toxin Type A 150kDa
7 Completed Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection
8 Completed Brain Stimulation to Treat Blepharospasm or Meige Syndrome
Conditions: Blepharospasm;   Focal Dystonia
Intervention: Procedure: repetitive transcranial magnetic stimulation (rTMS)
9 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
10 Completed Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Condition: Essential Blepharospasm
Intervention: Drug: Botulinum Toxin Type A
11 Completed
Has Results
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Drug: incobotulinumtoxinA (Xeomin);   Drug: Placebo
12 Completed
Has Results
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
13 Terminated Blepharospasm Short Interval
Condition: Blepharospasm
Intervention: Drug: NT 201
14 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Condition: Essential Blepharospasm
Interventions: Drug: Hugeltox;   Drug: Botulinum Toxin Type A(Botox®)
15 Not yet recruiting Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm
Condition: Pupillary Occlusion
Intervention:
16 Terminated Brain Changes in Blepharospasm
Conditions: Dystonia;   Focal Dystonia;   Cerebellar Disease
Intervention:
17 Recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units
18 Unknown  Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill
19 Completed Mexiletine for the Treatment of Focal Dystonia
Conditions: Blepharospasm;   Dystonia;   Spasm
Intervention: Drug: Mexiletine
20 Completed Movement Disorder Survey in East China
Conditions: Primary Dystonia;   Hemifacial Spasm
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years